Cluster newton method for sampling multiple solutions of an underdetermined inverse problem: Parameter identification for pharmacokinetics

In daily life, if we lack information for making a decision, we often consider multiple possibilities. However, if we are given an underdetermined inverse problem, we often add mathematically convenient constraints and consider only one of many possible solutions even though it may be beneficial for the application to consider multiple solutions. We propose an algorithm for simultaneously finding multiple solutions of an underdetermined inverse problem that are suitably distributed, guided by a priori information on which part of the solution manifold is of interest. Through numerical experiments, we show that our algorithm is a fast, accurate and robust solution method, especially applicable to ODE coefficient identification problems. We give an example of applying this algorithm to a parameter identification problem in pharmacokinetics. Cluster Newton Method for Inverse Problems 2

[1]  Lawrence F. Shampine,et al.  The MATLAB ODE Suite , 1997, SIAM J. Sci. Comput..

[2]  L. Wienkers,et al.  Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[3]  J. Robert,et al.  Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[4]  J. Robert,et al.  Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions. , 1998, Cancer research.

[5]  Åke Björck,et al.  Numerical methods for least square problems , 1996 .

[6]  J. Verweij,et al.  Hepatic transport, Metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drain , 2006, Cancer biology & therapy.

[7]  Ryuzo Azuma,et al.  Drug interaction prediction using ontology-driven hypothetical assertion framework for pathway generation followed by numerical simulation , 2008, BMC Bioinformatics.

[8]  C. V. Pesheck,et al.  Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[9]  R L Nation,et al.  Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine. , 2003, British journal of clinical pharmacology.

[10]  C. Guillemette,et al.  Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). , 2002, Molecular pharmacology.